array:19 [ "pii" => "S2387020624004157" "issn" => "23870206" "doi" => "10.1016/j.medcle.2024.04.015" "estado" => "S300" "fechaPublicacion" => "2024-10-18" "aid" => "6699" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Med Clin. 2024;163:323-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "323" "paginaFinal" => "326" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Rol de los bloqueantes neuromusculares en el desarrollo de polineuropatía y miopatía del enfermo crítico" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Fernando Armestar, Sara Vitoria Rubio, Isabel Ojanguren Sabán, Jaume Coll-Cantí, Hipólito Perez Molto" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Fernando" "apellidos" => "Armestar" ] 1 => array:2 [ "nombre" => "Sara" "apellidos" => "Vitoria Rubio" ] 2 => array:2 [ "nombre" => "Isabel" "apellidos" => "Ojanguren Sabán" ] 3 => array:2 [ "nombre" => "Jaume" "apellidos" => "Coll-Cantí" ] 4 => array:2 [ "nombre" => "Hipólito" "apellidos" => "Perez Molto" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775324003580" "doi" => "10.1016/j.medcli.2024.04.025" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775324003580?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624004157?idApp=UINPBA00004N" "url" => "/23870206/0000016300000007/v1_202410101439/S2387020624004157/v1_202410101439/en/main.assets" ]
Journal Information
Vol. 163. Issue 7.
Pages 323-326 (October 2024)
Vol. 163. Issue 7.
Pages 323-326 (October 2024)
Original article
Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients
Rol de los bloqueantes neuromusculares en el desarrollo de polineuropatía y miopatía del enfermo crítico
Fernando Armestar, Sara Vitoria Rubio, Isabel Ojanguren Sabán, Jaume Coll-Cantí, Hipólito Perez Molto
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail